Clinical Trials Logo

Renal Replacement Therapy clinical trials

View clinical trials related to Renal Replacement Therapy.

Filter by:

NCT ID: NCT06466421 Not yet recruiting - Hemodialysis Clinical Trials

Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis

Start date: July 1, 2024
Phase: Phase 4
Study type: Interventional

Several studies investigated the effectiveness of Gabapentin in Uremic Pruritus (UP). No previous studies investigated the use of fexofenadine in UP. The aim of this trial is to assess the safety and possible efficacy of fexofenadine in patients with UP.

NCT ID: NCT06285162 Not yet recruiting - Critically Ill Clinical Trials

Analgesia Nociception Index to Explore Autonomic Nervous System in Patients With Continuous Renal Replacement Therapy

UFANI
Start date: April 2024
Phase:
Study type: Observational

The Analgesia Nociception Index (ANI) reflects the balance between sympathetic and parasympathetic tone. It is based on a specific interpretation of the R-R interval variation. During fluid removal by net ultrafiltration in patients with fluid overload and continuous renal replacement therapy, some data suggest that haemodynamic variation could be induced by the autonomic nervous system. The study aims to investigate ANI variations in this context and their association with the haemodynamic variations observed.

NCT ID: NCT06226441 Recruiting - Sepsis Clinical Trials

Aminoglycoside Administration in Septic Patients

AMASEP
Start date: June 2, 2023
Phase: N/A
Study type: Interventional
Read more »
NCT ID: NCT06038162 Recruiting - Acute Kidney Injury Clinical Trials

Evaluation of Integrated Versus Parallel Connection for Renal Replacement Therapy in ECMO Patients

EPIC-ECMO
Start date: February 7, 2024
Phase: N/A
Study type: Interventional
Read more »
NCT ID: NCT05814341 Recruiting - Clinical trials for Renal Replacement Therapy

Citrate Anticoagulation in Renal Replacement Therapy: Impact of a High Post-filter Calcium Target on Efficacy

Ca-CIBLE
Start date: July 1, 2023
Phase: Phase 3
Study type: Interventional
Read more »
NCT ID: NCT05788211 Completed - Cardiogenic Shock Clinical Trials

REnal reCOVery After ECMO for Cardiogenic Shock (RECOVECMO)

RECOVECMO
Start date: January 1, 2022
Phase:
Study type: Observational

This retrospective study assesses long term renal outcome in patients having suffered medical or post cardiotomy refractory cardiogenic shock requiring renal replacement therapy (RRT) concomitant with veno-arterial extracorporeal membrane oxygenation (VA-ECMO). The authors seek to establish for accurate definition of renal recovery status predicting poor long-term renal outcomes.

NCT ID: NCT05666544 Recruiting - Clinical trials for End-stage Renal Disease

Renal Replacement Therapies Decision Aids

Start date: December 1, 2022
Phase: N/A
Study type: Interventional
Read more »
NCT ID: NCT05646615 Active, not recruiting - Quality of Life Clinical Trials

Experiences and Health-related Quality of Life of Informal Caregivers of Dialysis Patients

Start date: June 25, 2020
Phase:
Study type: Observational

The goal of this prospective, observational, multicentre cohort study is to assess the trajectory of the experiences (both positive and negative) and health-related quality of life (HRQOL) of informal caregivers of patients who start home dialysis, and compare these to experiences and HRQOL of informal caregivers of patients who start in-centre hemodialysis. The investigators hypothesise that informal caregivers of home dialysis patients experience more positive experiences, but also more negative experiences, and still have better HRQoL, compared with caregivers of in-centre HD patients. Participants will fill in five different validated questionnaires and questions on required support. Participants are asked to fill in the questionnaires after inclusion (i.e., start of dialysis), and at 6 and 12 months after start dialysis.

NCT ID: NCT05602129 Not yet recruiting - Clinical trials for Renal Replacement Therapy

A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects

Start date: November 2022
Phase: Phase 2
Study type: Interventional

This study is divided into Stage I and Stage II. It is planned to include 156 subjects who need CRRT treatment for more than 48 hours.

NCT ID: NCT04977687 Completed - Acute Kidney Injury Clinical Trials

Machine Learning Predict Renal Replacement Therapy After Cardiac Surgery

Start date: September 1, 2020
Phase:
Study type: Observational

Cardiac surgery-associated acute kidney injury (CSA-AKI) is a major complication which may result in adverse impact on short- and long-term mortality. The researcher here developed several prediction models based on machine learning technique to allow early identification of patients who at the high risk of unfavorable kidney outcomes. The retrospective study comprised 2108 consecutive patients who underwent cardiac surgery from January 2017 to December 2020.